Shanghai Fosun Pharmaceutical
Shanghai Fosun Pharmaceutical a leading healthcare company in China.
HQ location
Baoshan District, China
Website
Launch date
Employees
Market cap
$8.2b
Enterprise value
$10.8b
Share price
HKD16.88 2196.HK
Notable known LPs
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
* | CNY300m | Post IPO Equity | |
| Total Funding | 000k | ||
| CNY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 29 % | 13 % | (6 %) | (1 %) | 1 % | 5 % | 5 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 24 % | 24 % | 20 % | 21 % | 18 % | 15 % | 18 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 12 % | 8 % | 6 % | 7 % | 7 % | 8 % | 9 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 10 % | 10 % | 10 % | 9 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
ACQUISITION by BioMérieux Apr 2018
exited
ACQUISITION by Shanghai Fosun Pharmaceutical Mar 2017
ACQUISITION by Alphatec Spine Dec 2020
ACQUISITION by Shanghai Fosun Pharmaceutical Oct 2017
ACQUISITION by Shanghai Fosun Pharmaceutical Jun 2024